SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-12-240024
Filing Date
2012-05-18
Accepted
2012-05-18 16:07:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-1 d353583ds1.htm S-1 1311037
2 EX-5.1 d353583dex51.htm EX-5.1 5024
3 EX-23.1 d353583dex231.htm EX-23.1 1971
10 GRAPHIC g353583g30c85.jpg GRAPHIC 13925
11 GRAPHIC g353583rxi.jpg GRAPHIC 6398
  Complete submission text file 0001193125-12-240024.txt   3875874

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rxiii-20120331.xml EX-101.INS 505719
5 XBRL TAXONOMY EXTENSION SCHEMA rxiii-20120331.xsd EX-101.SCH 21166
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxiii-20120331_cal.xml EX-101.CAL 35772
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxiii-20120331_def.xml EX-101.DEF 84230
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxiii-20120331_lab.xml EX-101.LAB 149019
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxiii-20120331_pre.xml EX-101.PRE 101637
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 800-794-6027
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-181534 | Film No.: 12855589
SIC: 2834 Pharmaceutical Preparations